Eighth Annual Immuno-Oncology 360°

Samik Upadhaya, PhD, CRI Assistant Director, Scientific Affairs, speaks on the “Incorporating Advances in Biomarker Development to Inform Clinical Decisions and Lessons Learned” panel at 5:20 PM ET on Thursday, March 17, 2022. 

IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.

The 8th Annual Immuno-Oncology 360° delivers three key benefits:

  • Access to key opinion leaders driving the science
  • Partnership opportunities with all stakeholders in immuno-oncology
  • Presentations on the latest data impacting the science, clinical and business advancements in immuno-oncology

Learn more at io360summit.com

Photo by Jorge Gardner on Unsplash

Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

Father and son